8-144080552-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019037.3(EXOSC4):c.689G>A(p.Arg230Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000552 in 1,448,458 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019037.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOSC4 | NM_019037.3 | c.689G>A | p.Arg230Gln | missense_variant | Exon 3 of 3 | ENST00000316052.6 | NP_061910.1 | |
EXOSC4 | XM_011517134.4 | c.395G>A | p.Arg132Gln | missense_variant | Exon 3 of 3 | XP_011515436.1 | ||
LOC124902038 | XR_007061141.1 | n.1277C>T | non_coding_transcript_exon_variant | Exon 2 of 2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXOSC4 | ENST00000316052.6 | c.689G>A | p.Arg230Gln | missense_variant | Exon 3 of 3 | 1 | NM_019037.3 | ENSP00000315476.4 | ||
ENSG00000290230 | ENST00000703646.1 | n.689G>A | non_coding_transcript_exon_variant | Exon 3 of 8 | ENSP00000515414.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000552 AC: 8AN: 1448458Hom.: 0 Cov.: 31 AF XY: 0.00000555 AC XY: 4AN XY: 721040
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.689G>A (p.R230Q) alteration is located in exon 3 (coding exon 3) of the EXOSC4 gene. This alteration results from a G to A substitution at nucleotide position 689, causing the arginine (R) at amino acid position 230 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at